These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Comparative in vitro evaluation of BMY-28142, a new broad-spectrum cephalosporin, versus other beta-lactams against multiresistant gram-negative isolates. Giamarellou H, Sahin A, Chryssouli Z. Drugs Exp Clin Res; 1987; 13(3):149-53. PubMed ID: 3622243 [Abstract] [Full Text] [Related]
9. In vitro activity of imipenem towards gram-negative bacilli. Speciale A, Caccamo F, Pellegrino MB, Blandino G, Nicoletti G. Chemioterapia; 1986 Oct; 5(5):291-6. PubMed ID: 3466723 [Abstract] [Full Text] [Related]
14. In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria. Wang FD, Lin ML, Lee WS, Liu CY. Int J Antimicrob Agents; 2004 Jun; 23(6):590-5. PubMed ID: 15194130 [Abstract] [Full Text] [Related]
15. In vitro susceptibility of nosocomial Pseudomonas aeruginosa, enterobacteriaceae, and staphylococci to ciprofloxacin and ten other broad-spectrum antibiotics. Weinstein RA, Nathan C, Delzell D, Kabins SA. Chemioterapia; 1987 Oct; 6(5):315-8. PubMed ID: 3123078 [Abstract] [Full Text] [Related]
18. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions. Giamarellou H. Am J Med; 1986 Jun 30; 80(6B):126-37. PubMed ID: 3088998 [Abstract] [Full Text] [Related]